DOD’s 2Q Profit Jumps 324% in 2Q after Booking Higher Revenue from Sales

DOD Biotech Public Company Limited (DOD) has reported its 2Q20 consolidated financial statement through the Stock Exchange of Thailand as follows;

For the operating result of the second quarter ended June 30, 2020 compared with the same period of 2019, DOD generated the net profit for the year attributable to Owners of the parent by 76.74 million baht which was decreased by 58.89 million baht or 329.92% compared with the same period of last year, mainly due to the company had the revenue from sale of 430.49 million baht which was increased by 303.27 million baht or 238.38% compared with the same period of last year.